Commentary Open Access
Volume 3 | Issue 2 | DOI: https://doi.org/10.33696/cancerimmunol.3.046

Relevance of Neuropilin 1 and Neuropilin 2 Targeting for Cancer Treatment

  • 1Scientific Centre of Monaco, Biomedical Department, 8 quai Antoine 1er, MC-98000 Monaco, Principality of Monaco
  • 2University Cote D’Azur (UCA), Institute for research on cancer and aging of nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, Nice, France
+ Affiliations - Affiliations

Corresponding Author

Gilles Pagès, Gilles.Pages@unice.fr

Received Date: March 31, 2021

Accepted Date: April 30, 2021

Author Information X